Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
457.50    -4.00 (-0.87%)
Bid:
452.00
Ask:
463.50
Spread: 11.50 (2.544%)
Market Cap: £158.91m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Director/PDMR Shareholding

17 Sep 2020 12:18

RNS Number : 3290Z
Frontier Developments PLC
17 September 2020
 

Frontier Developments plc

Exercise of Options, Director/PDMR Shareholding and Total Voting Rights

Frontier Developments plc (AIM: FDEV, "Frontier", the "Company") announces that on 16 September 2020 in aggregate options over 21,189 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") were exercised under the Company's share option plans. Of the Ordinary Shares exercised, David Walsh, a Director of the Company, exercised 7,389 share options (the "Options") and subsequently sold 7,389 Ordinary Shares. The Company was also notified that Ann Cotton, a person closely associated ("PCA") with Charles Cotton, a Director of the Company, sold 1,927 Ordinary Shares on 16 September 2020.

The Options exercised and Ordinary Shares sold by the Director and PCA are set out in the tables below, together with the total number of Ordinary Shares each Director is interested in and holds under option.

 

Name of Director

Role

Number of Options exercised

Exercise price of Options exercised

Total Number of Options held following the exercise

David Walsh

Non-Executive Director

7,389

406p

23,648

 

Resultant Holding

Name of Director / PCA

Role

Ordinary shares sold

Price of Ordinary shares sold

Number of Ordinary Shares held following the sale

Percentage of issued share capital

David Walsh

Non-Executive Director

7,389

2,601p

3,500

0.01%

Ann Cotton

PCA of Non-Executive Director

1,927

2,598p

154,659(1)

0.39%(1)

 

(1)Including Charles Cotton's direct family holdings

 

Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that, following the exercise of Options, its issued share capital consists of 39,199,088 Ordinary Shares.

The Company does not currently hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 39,199,088.

 

The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries:

 

Frontier Developments  +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO 

 

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

 

Jefferies - Joint Broker  +44 (0)20 7029 8000

Max Jones / William Brown

 

Tulchan Communications  +44 (0)20 7353 4200

Matt Low / Deborah Roney / David Allchurch

 

 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Walsh

2.  

Reason for the notification

a)

Position/status: Non-Executive Director

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

a) Exercise of Options

b) Disposal of Ordinary Shares

c)

 

 

Price(s) and volume(s):

a)

Exercise Price(s)

Volume(s)

406p

7,389

 

b)

Sale Price(s)

Volume(s)

2,601p

7,389

d)

Aggregated information:

a) n/a - Single transaction

b) n/a - Single transaction

 

 

e)

Date of the transaction(s): 16 September 2020

f)

Place of the transaction:

a) Outside a trading venue

b) London Stock Exchange

 

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Ann Cotton, PCA of Charles Cotton

2.  

Reason for the notification

a)

Position/status: PCA of a Non-Executive Director

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Ordinary shares of 0.5p each

Identification code: GB00BBT32N39

b)

Nature of the transaction:

Disposal of Ordinary Shares

 

c)

 

 

Price(s) and volume(s):

Sale Price(s)

Volume(s)

2,598p

1,927

d)

Aggregated information:

n/a - Single transaction

 

e)

Date of the transaction(s): 16 September 2020

f)

Place of the transaction:

a) London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKOBDDBKDACD
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.